Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin M Murray

Showing results (121-130 of 593) with videos related to

Pageof 60
Sort By:
Translational Psychiatry|December 9, 2020
Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adultsAdrianna P Kępińska, James H MacCabe, Dorina Cadar, et al.
Psychological Medicine|May 7, 2019
Hospitalisation and length of hospital stay following first-episode psychosis: systematic review and meta-analysis of longitudinal studiesOlesya Ajnakina, Brendon Stubbs, Emma Francis, et al.
Brain, Behavior, and Immunity|January 26, 2020
Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosisValeria Mondelli, Marta Di Forti, B Paul Morgan, et al.
Archives of General Psychiatry|May 2, 2002
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohortMary Cannon, Avshalom Caspi, Terrie E Moffitt, et al.
NPJ Schizophrenia|June 24, 2016
Erratum: Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control studyMarco Colizzi, Conrad Iyegbe, John Powell, et al.
Schizophrenia Bulletin|October 5, 2023
Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic RelapseRobert A McCutcheon, David Taylor, Jose Rubio, et al.
The Journal of Clinical Psychiatry|March 29, 2007
Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorderOliver D Howes, Michael J Wheeler, Lyn S Pilowsky, et al.
Schizophrenia Research|April 11, 2021
Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studiesOlesya Ajnakina, Brendon Stubbs, Emma Francis, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 12, 2022
Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019Russell C Callaghan, Marcos Sanches, Robin M Murray, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 7, 2017
Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studiesJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Pageof 60

Showing results (121-130 of 593) with videos related to

Sort By:
Pageof 60
Translational Psychiatry|December 9, 2020
Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adultsAdrianna P Kępińska, James H MacCabe, Dorina Cadar, et al.
Psychological Medicine|May 7, 2019
Hospitalisation and length of hospital stay following first-episode psychosis: systematic review and meta-analysis of longitudinal studiesOlesya Ajnakina, Brendon Stubbs, Emma Francis, et al.
Brain, Behavior, and Immunity|January 26, 2020
Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosisValeria Mondelli, Marta Di Forti, B Paul Morgan, et al.
Archives of General Psychiatry|May 2, 2002
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohortMary Cannon, Avshalom Caspi, Terrie E Moffitt, et al.
NPJ Schizophrenia|June 24, 2016
Erratum: Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control studyMarco Colizzi, Conrad Iyegbe, John Powell, et al.
Schizophrenia Bulletin|October 5, 2023
Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic RelapseRobert A McCutcheon, David Taylor, Jose Rubio, et al.
The Journal of Clinical Psychiatry|March 29, 2007
Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorderOliver D Howes, Michael J Wheeler, Lyn S Pilowsky, et al.
Schizophrenia Research|April 11, 2021
Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studiesOlesya Ajnakina, Brendon Stubbs, Emma Francis, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 12, 2022
Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019Russell C Callaghan, Marcos Sanches, Robin M Murray, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 7, 2017
Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studiesJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Pageof 60